Laser treatment for peri-implantitis using two different wavelengths
An Evaluation Of Effectiveness Of A Combined Er:YAG And Nd:YAG Laser Protocol For Treatment Of Peri-Implantitis: A Randomized Controlled Trial
This study is testing whether a special laser treatment for gum disease around dental implants works better than regular cleaning methods for patients with peri-implantitis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 62 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cooperativa de Ensino Superior, Politécnico e Universitário Academic / other |
| Locations | 1 site (Porto) |
| Trial ID | NCT03819075 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a combined Er:YAG and Nd:YAG laser treatment protocol for patients diagnosed with peri-implantitis, comparing it to standard mechanical treatment. Participants will receive either the laser treatment or conventional care in a randomized controlled setup. The study aims to assess clinical outcomes over a follow-up period of at least 12 months, ensuring participants adhere to post-treatment care and hygiene recommendations.
Who should consider this trial
Good fit: Ideal candidates are individuals with at least one dental implant affected by peri-implantitis who can commit to follow-up visits.
Not a fit: Patients with serious systemic diseases, pregnancy, or those currently using certain medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a more effective and less invasive option for managing peri-implantitis, potentially improving patient outcomes.
How similar studies have performed: Other studies have shown promising results with laser treatments for peri-implantitis, suggesting potential efficacy of this combined approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * at least one implant with peri-implantitis * no serious mobility of the implants * written informed consent of the voluntary participant in the study * availability of participant for control visits for a follow-up of at least 12 months without interruptions Exclusion Criteria: * serious systematic disease * pregnancy * current use of photosensitive drugs, bisphosphonate medication or antibiotics * patients who do not want to follow post treatment recommendation of oral hygiene and follow-up visits
Where this trial is running
Porto
- Instituto Universitário de Ciências da Saude, CESPU — Porto, Portugal (Recruiting)
Study contacts
- Principal investigator: Luis Monteiro, DMD, PhD — Instituto Universitário de Ciências da Saude, CESPU
- Study coordinator: Luis Monteiro, DMD, PhD
- Email: luis.monteiro@iucs.cespu.pt
- Phone: +351 919120226
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.